Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New glasses aim to stop myopia in its tracks

NCT ID NCT07645183

Disease control Sponsor: University of Faisalabad Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two types of advanced glasses—lenslet spectacles and violet filter glasses—against standard single-vision lenses to see if they could slow the worsening of nearsightedness (myopia) in 90 people aged 8 to 20. Participants wore the glasses during all waking hours and had their eye measurements taken over 9 months. The goal was to find out if these high-tech lenses can control myopia better than regular glasses.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lenslet spectacles (Stellest with HALT technology) and violet excitation filter glasses (420 nm wavelength)
What this could lead to
If successful, these glasses could offer a non-invasive way to slow myopia progression in children and young adults, reducing the risk of severe nearsightedness later in life.
What could go wrong
This is a small, completed trial with 90 participants, so results may not apply to everyone. The effect may be modest, and long-term benefits beyond 9 months are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Jul 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 20 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of axial myopia (high, moderate, or severe) * Age between 8 and 20 years (inclusive) * Male or female * Willingness to wear prescribed glasses as instructed * Willingness to attend all follow-up visits (3, 6, and 9 months) * Written informed consent from participant or parent/guardian for minors Exclusion Criteria: * Any ametropia other than axial myopia (e.g., hyperopia, astigmatism \>1.50D) * Current contact lens users * Prior or concurrent myopia treatment other than study interventions * Any ocular disease (e.g., cataract, glaucoma, retinal disorders) * Any systemic disease affecting vision (e.g., diabetes, Marfan syndrome) * History of any ocular surgery * Allergic or physical intolerance to glasses materials * Non-cooperative patients unwilling to comply with study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myopia (disorder) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myopia refractive error

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myopia (disorder) Refraction error

Contacts and locations

Locations

  • The University of Faisalabad

    Faisalābad, Punjab Province, 3800, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.